Cited by 799Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and LipoproteinsAdipose Tissue and Metabolism

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance

Open access
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., Pratley, R. E.·2000·Diabetologia

Abstract

Aims/hypothesis Cross-sectional studies indicate that enlarged subcutaneous abdominal adipocyte size is associated with hyperinsulinaemia, insulin resistance and glucose intolerance. To further explore the pathophysiological significance of these associations, we examined prospectively whether enlarged subcutaneous abdominal adipocyte size predicts Type II (non-insulin-dependent) diabetes mellitus.Methods Body composition (hydrodensitometry), mean subcutaneous abdominal adipocyte size (fat biopsy), insulin sensitivity (hyperinsulinaemic clamp) and the acute insulin secretory response (25-g i.v. GTT) were assessed in 280 Pima Indians with either normal (NGT), impaired (IGT) or diabetic glucose tolerance (75-g OGTT). Subjects with NGT were then followed prospectively.Results After adjusting for age, sex and per cent body fat, mean subcutaneous abdominal adipocyte size was 19% and 11% higher in subjects with diabetes and IGT, compared with those with NGT (p < 0.001). Insulin sensitivity was inversely correlated with mean subcutaneous abdominal adipocyte size (r = -0.53, p < 0.0001), even after adjusting for per cent body fat (r = -0.31, p < 0.001). In 108 NGT subjects followed over 9.3 +/- 4.1 years (33 of whom developed diabetes), enlarged mean subcutaneous abdominal adipocyte size but not high per cent body fat, was an independent predictor of diabetes, in addition to a low insulin sensitivity and acute insulin secretory response [relative hazard 10th vs 90th centile (95% CI): 5.8 (1.7-19.6), p < 0.005]. In 28 NGT subjects with a 9% weight gain over 2.7 +/- 1.3 years, changes in insulin sensitivity were inversely and independently related to changes in mean subcutaneous abdominal adipocyte size and per cent body fat.Conclusion/interpretation Although enlarged mean subcutaneous abdominal adipocyte size is associated with insulin resistance cross-sectionally, prospectively, both abnormalities are independent and additive predictors of Type II diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s001250051560

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proinflammatory cytokine signalling activates IKKb and JNK1, which phosphorylate Ser307 of IRS-1, preventing insulin receptor tyrosine phosphorylation and downstream signalling.

    “Proinflammatory cytokine signalling usually activates the kinases IkB kinase b and C-jun N-terminal kinase 1, both of which in turn phosphorylate the Ser 307 residue of insulin receptor substrate (IRS)-1.This prevents the phosphorylation of tyrosine residues of IRS-1 by the insulin receptor and the downstream signalling cascade.”
  • In vitro, hepatocytes, muscle cells, adipocytes and endothelial cells respond to TNF-a, IL-6 and/or IL-1b with impaired insulin signalling.

    “Experimental model systems in vitro have shown that hepatocytes as well as muscle cells, adipocytes and endothelial cells respond to exposure to the pro-inflammatory cytokines TNF-a, IL-6 and/or IL-1b with impaired insulin signalling (128) .”
  • Paracrine concentrations of inflammatory mediators are sufficient to induce insulin resistance.

    “Paracrine concentrations of inflammatory mediators are sufficient to induce insulin resistance (128) .”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [40]40. Weyer C, Salbe AD, Lindsay R, Bogardus C, Pratley RE, Tataranni PA (2001) Exaggerated pancreatic polypeptide secretion in Pima Indians: can increased parasympathetic drive to the pancreas contribute to hyperinsulinemia and diabetes in humans? Metabolism, in press.

Cited by

Sorted by citations

Authors
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E.
Affiliations
National Institutes of Health (US)
Venue
Diabetologia
Published
2000-11-30
Volume
43
Issue
12
Pages
1498-1506
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2006433855
Cited by
799
References
43
Citations by year
2026: 17 · 2025: 28 · 2024: 31 · 2023: 27 · 2022: 31 · 2021: 31 · 2020: 35 · 2019: 26 · 2018: 40 · 2017: 45 · 2016: 36 · 2015: 45 · 2014: 40 · 2013: 48 · 2012: 35
FWCI
8.02
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
type 2 diabetes, insulin resistance, impaired glucose tolerance, Pima Indians, insulin sensitivity, body fat percentage, weight gain, diabetes prediction, adipocyte hypertrophy
MeSH terms
Abdomen, Adipose Tissue, Adult, Blood Glucose, Body Composition, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Lipolysis, Longitudinal Studies, Male, Obesity, Predictive Value of Tests, Prospective Studies, Regression Analysis, Glucose Clamp Technique, Adipocytes, Cell Size

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review